Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal
Ye Chen, … , William Stohl, Song Guo Zheng
Ye Chen, … , William Stohl, Song Guo Zheng
Published September 26, 2024
Citation Information: JCI Insight. 2024;9(21):e183400. https://doi.org/10.1172/jci.insight.183400.
View: Text | PDF
Research Article Immunology

BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal

  • Text
  • PDF
Abstract

T follicular helper (Tfh) cells represent an important subset of CD4+ T cells that is crucial to the maturation and differentiation of B cells and the production of high-affinity antibodies. Because B cell activating–factor (BAFF), a vital B cell survival factor, is also crucial to B cell maturation and differentiation, we assessed the effects of BAFF on Tfh cell development and function. We demonstrated that deficiency of BAFF, but not of APRIL, markedly inhibited Tfh cell development, germinal center (GC) formation, and antigen-specific antibody production. The promoting effect of BAFF on Tfh cell development was dependent on expression of BR3 on T cells, and its promoting effect on GC formation was dependent on expression of BR3 on both T cells and B cells. BAFF directly promoted expression of the Tfh cell–characteristic genes via NF-κB signaling. This effect did need BR3 expression. Thus, BAFF not only has direct effects on B cells, but it also has direct effects on Tfh cell differentiation via engagement of BR3, which collectively promoted GC formation and production of high-affinity antibodies. This dual effect of BAFF on B cells and Tfh cells may help explain the clinical utility of BAFF antagonists in the management of certain autoimmune diseases.

Authors

Ye Chen, Maogen Chen, Yu Liu, Qiang Li, Youqiu Xue, Liu Liu, Rongzhen Liang, Yiding Xiong, Jun Zhao, Jingrong Chen, Weidong Lin, Julie Wang, Yun Feng Pan, William Stohl, Song Guo Zheng

×

Figure 1

In vivo generation of Tfh cells requires BAFF but not APRIL.

Options: View larger image (or click on image) Download as PowerPoint
In vivo generation of Tfh cells requires BAFF but not APRIL.
WT, April–/...
WT, April–/–, Baff–/–, April–/–.Baff–/–, or Baff transgenic mice were immunized with keyhole limpet hemocyanin (KLH) emulsified in complete Freund’s adjuvant (CFA), and mice were euthanized 10 days after immunization. (A) Gating strategy for CD4+ T cells. (B and C) The percentages of Tfh cells among CD4+ T cells in draining lymph nodes (dLN) were determined by flow cytometry. The representative flow data (B) and the statistical data (C) are shown. (D) Confocal microscopy of germinal centers of LNs. (E and F) ELISA for KLH-specific IgG and IgG2a in serum (n = 3–5 mice per group). Data are presented as mean ± SEM. Data are representative of 3 independent experiments. P values were calculated by 1-way ANOVA (C) or 2-way ANOVA (E and F) with a Tukey’s multiple comparison test. For E, statistical analysis was performed specifically for the 1:10,000 condition. **P < 0.01, ****P < 0.0001.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts